Board of Directors
Our Board of Directors, listed below, is comprised of MPN patients, MPN patient family members, MPN carers, as well as leaders from Canadian industry and non-profits.
Their collective expertise provides critical Leadership and Governance to the Foundation's operations. That same expertise also informs the robust analysis and decision-making process the Board applies to the review of potential research projects.
CMPNRF Board of Directors
Cheryl’s role of Executive Director of the Canadian MPN Research Foundation is a natural fit. Cheryl is a graduate of the Bachelor of Management Program of University of Lethbridge, and her MBA in Community Economic Development from Cape Breton University.
Cheryl has served the non-profit community for many years and is very fluent in the organizational framework of non-profits. Cheryl has come to the MPN community as a caregiver to her late husband Eugene who was diagnosed with Essential Thrombocythemia
in 1992 and progressed to MF in 2010. Throughout Eugene’s journey, Cheryl wanted to ensure that mpn patients received the most up to date information and resources that they could have to navigate their journey with an MPN Blood Cancer. Cheryl is active on the Board of Directors of the MPN Research Foundation in Chicago, the MPN Advocates Network based out of Europe. Cheryl is a sought-after speaker at many events bringing the patient voice to the forefront of the discussion of patient centricity.
Cheryl brings a combination of her business skills and her not for profit background to an organization that she is passionate about serving! Cheryl looks forward to working with the Board and the Medical Advisory committee in pursuit of research in Canada for MPN blood cancers to look at better treatment options and of course a cure!
Tony Comper, C.M.
Past President and C.E.O, BMO Financial Group
Tony Comper was appointed CEO of BMO Financial Group in February 1999, and also served as Chairman from July 1999 to May 2004, when the bank moved to a non-executive Chairman model. Member of the International Advisory Committee, Li Ka Shing Knowledge Institute of St. Michael’s Hospital; Honorary Chair, Board of Governors of the Yee Hong Centre for Geriatric Care; The Advisory Board for The Conference Board of Canada/Spencer Stuart National Governance Award and Member of the Investment Committee, Catalyst; served as Independent Lead Director of Spectra Energy
Corporation, Houston; Served as Chair of the Board of Directors, PPP Canada; He received the Human Relations Award from the Canadian Council of Christians and Jews &; the Award of Merit from B’nai Brith Canada He holds honorary degrees from the University of Toronto (LL.D.), Mount Saint Vincent University (D.Hum.L), the University of New Brunswick (D.Litt.); and Haifa University with his late wife Elizabeth.
Tony and his late wife Elizabeth also received the Scopus Award from the Hebrew University of Jerusalem. They also founded FAST, a new initiative to combat antisemitism in Canada. In November 2009, Concordia University conferred the degree of Doctor of Philosophy (Honoris Causa) on Tony and his wife Elizabeth. In January 2011, he received the Order of Canada together with his wife Elizabeth.
President, CEO Kombi Sports
In 2016 Ed joined the Canadian MPN Network (CMPNN) as Quebec's representative. Then, in 2018 he became a founding member of the Canadian MPN Research Foundation (CMPNRF) and transitioned to our Board.
Ed is also the Chairman of the Board/Président du conseil of Kombi Sports Inc - a Canadian based leading international sports accessories brand. And he's also a proud graduate of McGill University.
Ed was first diagnosed with Polycythemia Vera (PV) several years ago and remains passionate about both patient advocacy and innovative research initiatives.
Dr. Vikas Gupta
MMD, FRCP, FRCPath
Dr. Gupta is site lead for the Elizabeth and Tony Comper MPN Program, and a member of the Leukemia/MPN Program at Princess Margaret Cancer Centre. He is the founding member and president of the Canadian MPN Group. His clinical and research activities are focused on developing novel transplant and non-transplant based treatment strategies for patients with myeloid malignancies, in particular, myeloproliferative neoplasms.
Merrill is the Founder & President CEO of The Pierce Group, a division of MPSquared Coaching Canada, specializing in providing Executive Coaching & CEO Peer Advisory Groups. Merrill is a Professional Certified Coach (PCC) accredited by the International Coach Federation. She is also a member of the Society of Organized Learning (SOL) Community of Coaches at Harvard, specializing in coaching from a systems perspective. This is complemented by certification in Alternative Dispute Resolution (ADR Mediation) from the University of Windsor Law School.
Additionally, Merrill is also accredited by Insights Learning & Development, a global leader in the field of people and organizational development, to facilitate and administer psychometric/personality testing.
In addition to comprehensive professional training, Merrill has over 15 years of insight and experience as a senior executive herself (in the advertising industry working with such prestigious clients as Nestle, Quaker Oats, Bank of Montreal, Canadian Airlines, McDonalds Restaurants, Estee Lauder, Yamaha and Prince Edward Island Tourism) that she brings to her role as Head Coach.
As well as directing the day-to-day management of MPSquared Coaching Merrill makes time for additional responsibilities; She is a professor at Humber College’s School of Media Studies and Business School Graduate Program teaching ‘Marketing and Account Management’, and is the Chair of The Pierce Peer Advisory group for C-Suite and senior level executives.
Merrill is a contributor and industry expert on (Goldhawk Live, 2nd Chances), radio (What She Said) and as a conference panellist and Keynote speaker at (DW Ignite). She is the author of Regeneration “Define Your Path” which was commissioned by The Bank of Montreal and in 2016 she was the proud recipient of Distinctive Women Awards: Professional of the Year.
Vice Chair, P.ENG, MBA
Mike Brady is a highly effective executive with a proven track record for success. Mike possesses both startup and blue-chip corporate leadership experience. Passionate public speaker and active member of the community. Mike Brady is
responsible for leading Trillion LLC.’s commercial operations as Chief Commercial Officer and Board Director & Secretary. Mr. Brady’s area of expertise lies with capital equipment sales and marketing, sales team development, international business development, strategic planning, finance, commercial contract negotiations, and relations.
He has worked for 20+ years in the energy industry on an international basis both as a domestic employee and an expatriate, namely in NA, SA, EU and MENA.
Mike’s previous career experiences include 18 years combined with Aecon Group Inc. and Babcock & Wilcox Canada in vice president leadership roles related to sales, business development, marketing, strategic planning & general management. Mr. Brady has been very active in oil & gas and power generation projects, globally and throughout his career. He holds a Professional Engineering License, a Bachelor of Engineering Science from Western University and an MBA from the Richard Ivey School of Business, Western University.
Mike is Vice Chair, BOD of the Canadian MPN Research Foundation and a BOD Member of the Canadian MPN Patient Network. Mike was a former Canadian Cancer Society Ontario Nominating and Governance Committee member. Mike’s charitable work and public speaking initiatives can be found at www.mikebrady.ca. Mike is also an active athlete participating in long-distance road bike rides, weight training, yoga and mindfulness activities.
Entrepreneur, Co Founder at your Music Memory
Jeff is a successful business entrepreneur in Toronto Canada.
Jeff is a member of the Board of Directors for the Canadian MPN Research Foundation, and brings his vast knowledge of his Board experience with the MPN Research Foundation in Chicago Illinois.
18 Nursewood Rd
Tel: 844 644 6766
Our Mission is to stimulate original Canadian research in pursuit of new treatment options - and ultimately a cure - for the blood cancers collectively known as myeloproliferative neoplasms (MPNs).
CRA Registered Charity # 748799723 RR 001